Importance Multiple cases of autoimmune and autoinflammatory diseases after COVID-19
have been reported. However, their incidences and risks have rarely been quantified …

Background There are a growing number of case reports of various autoimmune diseases
occurring after COVID-19, yet there is no large-scale population-based evidence to support …

Background Real-world evidence on the association between autoimmune inflammatory
rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are …

Objectives To investigate whether the risk of developing an incident autoimmune disease is
increased in patients with prior COVID-19 disease compared to those without COVID-19, a …

Background: Some data suggest a higher incidence of diagnosis of autoimmune
inflammatory rheumatic diseases (AIRDs) among patients with a history of COVID-19 …

Introduction: Over 4.9 million cases of Coronavirus disease 2019 (COVID-19) have been
confirmed since the worldwide pandemic began. Since the emergence of COVID-19, a …

The full picture of post-COVID-19 autoimmune diseases and their prevalence is lacking
despite numerous case reports and small series. Two studies that use large cohorts now …

Background: Numerous cases of the coronavirus disease 2019 (COVID-19) with
autoimmune and rheumatic manifestations have been reported. Despite the available …

Background In the ongoing COVID-19 pandemic, the susceptibility of patients with rheumatic
diseases to COVID-19 remains unclear. We aimed to investigate susceptibility to COVID-19 …

Objective Patients with systemic autoimmune rheumatic diseases (ARDs) continue to be
concerned about risks of severe coronavirus disease 2019 (COVID‐19) outcomes. This …